Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value
$39.47−0.51 (-1.28%)
Close on Nov 13, 2026Market cap $51.89BP/E –Yield –
Medline ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Medline's ebitda for the twelve months ending Sep 26, 2026 was $2.77B. For fiscal 2025 it was $3.22B, up 3.2% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.22B | +3.2% |
| FY2024 | Dec 31, 2024 | $3.12B | +41.9% |
| FY2023 | Dec 31, 2023 | $2.20B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $759.00M | -8.2% |
| Q2 FY2026 | Jun 27, 2026 | $651.00M | -27.0% |
| Q1 FY2026 | Mar 28, 2026 | $676.00M | -17.4% |
| Q4 FY2025 | Dec 31, 2025 | $686.00M | – |
| Q3 FY2025 | Sep 27, 2025 | $827.00M | – |
| Q2 FY2025 | Jun 28, 2025 | $892.00M | – |
| Q1 FY2025 | Mar 29, 2025 | $818.00M | – |
See a number that looks wrong?